IL6 and COVID-19: In the current study, we found that uPAR expression was decreased in the lung tissue of COVID-19 patients, which could have led to the pro-fibrogenic accumulation of inactive uPA followed by IL-6 and ACE2 upregulation and EMT induction in lung epithelial cells.